NEW YORK (GenomeWeb) – Australian molecular diagnostics firm Genetic Technologies today reported a 41 percent drop in cash receipts from customers in its fiscal second quarter compared with the previous quarter.

For the three-month period ended Dec. 31, Genetic Technologies' cash receipts fell to A$106,000 (US$85,765) from A$179,000 in fiscal Q1. Meanwhile, the company reported a 55 percent year-over-year drop in test samples received to 125 from 278. In the fiscal first quarter, the company received 115 test samples.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.